Phase I Study of an Oral Histone Deacetylase Inhibitor, Suberoylanilide Hydroxamic Acid, in Patients With Advanced Cancer
Top Cited Papers
- 10 June 2005
- journal article
- clinical trial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 23 (17), 3923-3931
- https://doi.org/10.1200/jco.2005.14.167
Abstract
Purpose To determine the safety, dosing schedules, pharmacokinetic profile, and biologic effect of orally administered histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) in patien...Keywords
This publication has 19 references indexed in Scilit:
- Histone Deacetylase Inhibitors Restore Radioiodide Uptake and Retention in Poorly Differentiated and Anaplastic Thyroid Cancer Cells by Expression of the Sodium/Iodide Symporter Thyroperoxidase and ThyroglobulinEndocrinology, 2004
- Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphomaBlood, 2003
- Regulating the RegulatorsCell, 2003
- Acetylation inactivates the transcriptional repressor BCL6Nature Genetics, 2002
- The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxinProceedings of the National Academy of Sciences, 2002
- A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancerNature Genetics, 2002
- The human programmed cell death-2 (PDCD2) gene is a target of BCL6 repression: Implications for a role of BCL6 in the down-regulation of apoptosisProceedings of the National Academy of Sciences, 2002
- Histone Deacetylase Inhibitor Downregulation of bcl-xl Gene Expression Leads to Apoptotic Cell Death in MesotheliomaAmerican Journal of Respiratory Cell and Molecular Biology, 2001
- Low Concentrations of the Histone Deacetylase Inhibitor, Depsipeptide (FR901228), Increase Expression of the Na + /I ? Symporter and Iodine Accumulation in Poorly Differentiated Thyroid Carcinoma CellsJournal of Clinical Endocrinology & Metabolism, 2001
- Low Concentrations of the Histone Deacetylase Inhibitor, Depsipeptide (FR901228), Increase Expression of the Na+/I- Symporter and Iodine Accumulation in Poorly Differentiated Thyroid Carcinoma CellsJournal of Clinical Endocrinology & Metabolism, 2001